KR
Kristian Reich sold $878K of MLTX stock
Kristian Reich, Chief Scientific Officer of MoonLake Immunotherapeutics (MLTX), sold 43,700 shares of MLTX stock worth $878K, per an SEC Form 4 filed Jul 21, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 20, 2026, 1 day before it was made public.
MLTX has moved -34.1% since the trade date, from $19.05 to $12.56 (Nov 10, 2026 close).
- Traded
- Jul 20, 2026
- Disclosed
- Jul 21, 2026
- Filing delay
- 1 day
- Price since
- -34.1%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4